Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Letterer-Siwe Disease | Kisho | Kisho

Back to Letterer-Siwe Disease

Letterer-Siwe Disease — NIH Grants & Funding

Active and recent NIH-funded research on Letterer-Siwe Disease. Data from NIH RePORTER, last 36 months.

MONDO:0009519

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Letterer-Siwe Disease has emerging NIH research funding with 3 grants totaling $4.6M.

3funded grants from NIH

Portfolio: $783KCumulative: $4.6M1 active2 completed5 PIs3 institutions

By Research Theme

Basic Science

Epi / Nat. History

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$1.3M

FY22

$1.3M

FY23

$667K

FY24

$687K

FY25

$643K

FY26

By Funding Mechanism

R01

F30

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Letterer-Siwe Disease. Strongest funded area: Basic Science. Largest gap: Basic Science.

Clinical ResearchTrials Active, No NIH Grants

14 clinical trials registered but no NIH-funded clinical or translational research grants found for letterer-Siwe disease. Trials may be industry-sponsored or funded through non-NIH sources.

Basic ScienceFunded, Few Publications

2 funded grants in Basic Science but only 0 related publications found for letterer-Siwe disease. This may indicate early-stage research that hasn't yet produced published results.

Adjacent Research(3 grants)

These grants mention Letterer-Siwe Disease as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(3)

OtherR37Active

Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms

Diamond, Eli·SLOAN-KETTERING INST CAN RESEARCH·NEW YORK, NY

$553,980 (FY2025)

NIH RePORTER

OtherUG1Completed

COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children

MESHINCHI, SOHEIL·PUBLIC HEALTH INSTITUTE·OAKLAND, CA

$427,843 (FY2024)

NIH RePORTER

OtherR13Completed

Defining Clinical Research Priorities and Strengthening Diversity and Patient-Stakeholder Engagement in Histiocytic Disorders

ALLEN, CARL et al.·ST. JUDE CHILDREN'S RESEARCH HOSPITAL·MEMPHIS, TN

$30,000 (FY2024)

NIH RePORTER

Kisho

Letterer-Siwe Disease — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(3 grants)

Other(3)

Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms

COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children

Defining Clinical Research Priorities and Strengthening Diversity and Patient-Stakeholder Engagement in Histiocytic Disorders

Top Funded Institutions

Top Principal Investigators